Taheri A, Golshadi Z, Zare H, Alinaghipour A, Faghihi Z, Dadgostar E
Cell Mol Neurobiol. 2024; 44(1):28.
PMID: 38461204
PMC: 10924707.
DOI: 10.1007/s10571-024-01461-w.
de Rus Jacquet A, Alpaugh M, Denis H, Tancredi J, Boutin M, Decaestecker J
Nat Commun. 2023; 14(1):3651.
PMID: 37339976
PMC: 10282096.
DOI: 10.1038/s41467-023-39038-8.
Nainu F, Mamada S, Harapan H, Emran T
Adv Exp Med Biol. 2023; 1411:39-70.
PMID: 36949305
DOI: 10.1007/978-981-19-7376-5_3.
de Rus Jacquet A, Tancredi J, Lemire A, DeSantis M, Li W, OShea E
Elife. 2021; 10.
PMID: 34590578
PMC: 8514240.
DOI: 10.7554/eLife.73062.
Patrick K, Watson R
Infect Immun. 2021; 89(4).
PMID: 33558322
PMC: 8090963.
DOI: 10.1128/IAI.00687-20.
Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics.
Sanstrum B, Goo B, Holden D, Delgado D, Nguyen T, Lee K
Molecules. 2020; 25(11).
PMID: 32486414
PMC: 7321188.
DOI: 10.3390/molecules25112561.
Improvements of Motor Performances in the Loss-of-Function Model of Parkinson's Disease: Effects of Dialyzed Leucocyte Extracts from Human Serum.
Diana A, Collu M, Casu M, Mocci I, Aguilar-Santelises M, Setzu M
Brain Sci. 2020; 10(1).
PMID: 31947539
PMC: 7017078.
DOI: 10.3390/brainsci10010045.
G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson's Disease?.
Ren C, Ding Y, Wei S, Guan L, Zhang C, Ji Y
Front Hum Neurosci. 2019; 13:306.
PMID: 31551736
PMC: 6738350.
DOI: 10.3389/fnhum.2019.00306.
Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice.
Pellegrini L, Hauser D, Li Y, Mamais A, Beilina A, Kumaran R
Hum Mol Genet. 2018; 27(18):3257-3271.
PMID: 29917075
PMC: 6121185.
DOI: 10.1093/hmg/ddy232.
Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease.
Ryter S, Bhatia D, Choi M
Antioxid Redox Signal. 2018; 30(1):138-159.
PMID: 29463101
PMC: 6251060.
DOI: 10.1089/ars.2018.7518.
Synthesis and In Vitro and In Vivo Evaluation of [H]LRRK2-IN-1 as a Novel Radioligand for LRRK2.
Malik N, Gifford A, Sandell J, Tuchman D, Ding Y
Mol Imaging Biol. 2017; 19(6):837-845.
PMID: 28289968
PMC: 5597475.
DOI: 10.1007/s11307-017-1070-1.
Effects of bile acids on neurological function and disease.
McMillin M, DeMorrow S
FASEB J. 2016; 30(11):3658-3668.
PMID: 27468758
PMC: 5067249.
DOI: 10.1096/fj.201600275R.
Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration.
De Rose F, Marotta R, Poddighe S, Talani G, Catelani T, Setzu M
PLoS One. 2016; 11(1):e0146140.
PMID: 26727265
PMC: 4699764.
DOI: 10.1371/journal.pone.0146140.
Endocytic membrane trafficking and neurodegenerative disease.
Schreij A, Fon E, McPherson P
Cell Mol Life Sci. 2016; 73(8):1529-45.
PMID: 26721251
PMC: 11108351.
DOI: 10.1007/s00018-015-2105-x.
Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach.
Nah J, Yuan J, Jung Y
Mol Cells. 2015; 38(5):381-9.
PMID: 25896254
PMC: 4443278.
DOI: 10.14348/molcells.2015.0034.
Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain.
Piccoli G, Onofri F, Cirnaru M, Kaiser C, Jagtap P, Kastenmuller A
Mol Cell Biol. 2014; 34(12):2147-61.
PMID: 24687852
PMC: 4054300.
DOI: 10.1128/MCB.00914-13.
Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.
Liu M, Bender S, Cuny G, Sherman W, Glicksman M, Ray S
Biochemistry. 2013; 52(10):1725-36.
PMID: 23379419
PMC: 3966205.
DOI: 10.1021/bi3012077.
The endotoxin-induced neuroinflammation model of Parkinson's disease.
Tufekci K, Genc S, Genc K
Parkinsons Dis. 2011; 2011:487450.
PMID: 21331154
PMC: 3034925.
DOI: 10.4061/2011/487450.
LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.
Piccoli G, Condliffe S, Bauer M, Giesert F, Boldt K, De Astis S
J Neurosci. 2011; 31(6):2225-37.
PMID: 21307259
PMC: 6633036.
DOI: 10.1523/JNEUROSCI.3730-10.2011.
Parkinson's disease: Exit toxins, enter genetics.
Westerlund M, Hoffer B, Olson L
Prog Neurobiol. 2009; 90(2):146-56.
PMID: 19925845
PMC: 4155944.
DOI: 10.1016/j.pneurobio.2009.11.001.
